HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.

Abstract
Connective tissue growth factor (CTGF) is involved in inflammation, pathogenesis and progression of liver fibrosis. Matrix metalloproteinase-13 (MMP-13) cleaves CTGF and releases several fragments, which are more potent than the parent molecule to induce fibrosis. The current study was aimed to elucidate the significance of MMP-13 and CTGF and their downstream effects in liver injury and fibrosis. Hepatic fibrosis was induced using intraperitoneal injections of N-nitrosodimethylamine (NDMA) in doses of 10 μg/g body weight on three consecutive days of each week over a period of 4 weeks in both wild-type (WT) and MMP-13 knockout mice. Administration of NDMA resulted in marked elevation of AST, ALT, TGF-β1 and hyaluronic acid in the serum and activation of stellate cells, massive necrosis, deposition of collagen fibres and increase in total collagen in the liver of WT mice with a significant decrease in MMP-13 knockout mice. Protein and mRNA levels of CTGF, TGF-β1, α-SMA and type I collagen and the levels of MMP-2, MMP-9 and cleaved products of CTGF were markedly increased in NDMA-treated WT mice compared to the MMP-13 knockout mice. Blocking of MMP-13 with CL-82198 in hepatic stellate cell cultures resulted in marked decrease of the staining intensity of CTGF as well as protein levels of full-length CTGF and its C-terminal fragments and active TGF-β1. The data demonstrate that MMP-13 and CTGF play a crucial role in modulation of fibrogenic mediators and promote hepatic fibrogenesis. Furthermore, the study suggests that blocking of MMP-13 and CTGF has potential therapeutic implications to arrest liver fibrosis.
AuthorsJoseph George, Mikihiro Tsutsumi, Mutsumi Tsuchishima
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 21 Issue 12 Pg. 3821-3835 (Dec 2017) ISSN: 1582-4934 [Electronic] England
PMID28782260 (Publication Type: Journal Article)
Copyright© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Chemical References
  • Actins
  • CCN2 protein, mouse
  • Collagen Type I
  • Transforming Growth Factor beta1
  • alpha-smooth muscle actin, mouse
  • Connective Tissue Growth Factor
  • Hyaluronic Acid
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Matrix Metalloproteinase 13
  • Mmp13 protein, mouse
  • Dimethylnitrosamine
Topics
  • Actins (genetics, metabolism)
  • Alanine Transaminase (blood)
  • Animals
  • Aspartate Aminotransferases (blood)
  • Chemical and Drug Induced Liver Injury (genetics, metabolism, pathology, prevention & control)
  • Collagen Type I (genetics, metabolism)
  • Connective Tissue Growth Factor (genetics, metabolism)
  • Dimethylnitrosamine
  • Female
  • Gene Expression Regulation
  • Hepatic Stellate Cells (cytology, drug effects, metabolism)
  • Hyaluronic Acid (blood)
  • Injections, Intraperitoneal
  • Liver (metabolism, pathology)
  • Liver Cirrhosis (chemically induced, genetics, metabolism, prevention & control)
  • Male
  • Matrix Metalloproteinase 13 (deficiency, genetics)
  • Mice
  • Mice, Knockout
  • Primary Cell Culture
  • Proteolysis
  • Signal Transduction
  • Transforming Growth Factor beta1 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: